We're a team of passionate individuals from diverse backgrounds that are dedicated to helping patients access the information they need to lower their cancer risk.
In the fight against cancer, genes are key. Genetic tests, along with a patient’s lifestyle markers (diet, exercise, smoking), can clearly signal when pre-emptive strategies should be implemented. But unless genetic services can be made more practical, physicians often skip the process altogether.
CancerIQ's "cancer risk clinic in a box" makes it faster and less expensive for physicians to identify high-risk patients and navigate them towards services that can pre-empt or prevent cancer. By automating the most time-consuming admin tasks that keep community-based physicians from offering genetic services, we improve patient access to life-saving medical care. Our product suite contains predictive analytics and screening tools to identify at-risk patients; clinical guidance with proven outcomes; a digital genetic test ordering platform and patient management and education tools.
Feyi received both her Bachelor’s and MBA from The Wharton School. Prior to CancerIQ, she worked as a management consultant, investor,
Haibo received his Bachelor’s in Economics and Psychology at Harvard University and his MBA from the University of Chicago Booth School of Business
Dr. Olopade is a medical oncologist and Founder of the Clinical Cancer Genetics Program at the University of Chicago Medicine...